These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 2232434

  • 1. [Adverse reactions of antituberculous agents, especially about its onset and duration].
    Yamada H, Yasuoka A, Sasayama K, Doutsu Y, Hayashi T, Kohno S, Yamaguchi K, Hirota M, Hara K.
    Kekkaku; 1990 Sep; 65(9):563-8. PubMed ID: 2232434
    [Abstract] [Full Text] [Related]

  • 2. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H.
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [Abstract] [Full Text] [Related]

  • 3. [Desensitization therapy for allergic reactions of antituberculous drugs--evaluation of desensitization therapy according to the guideline of the Japanese Society for Tuberculosis].
    Kobashi Y, Okimoto N, Matsushima T, Abe T, Nishimura K, Shishido S, Kawahara S, Shigeto E, Takeyama H, Kuraoka T.
    Kekkaku; 2000 Dec; 75(12):699-704. PubMed ID: 11201137
    [Abstract] [Full Text] [Related]

  • 4. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].
    Shishido Y, Nagayama N, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Komatsu H, Yotsumoto H.
    Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045
    [Abstract] [Full Text] [Related]

  • 5. HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone free anti-tuberculosis treatment in Yaounde, Cameroon.
    Kuaban C, Bercion R, Koulla-Shiro S.
    East Afr Med J; 1997 Aug; 74(8):474-7. PubMed ID: 9487410
    [Abstract] [Full Text] [Related]

  • 6. Liver function tests in patients of pulmonary tuberculosis using four different drug regimens.
    Akbri MZ, Fatima N, ul Haque E, Shiekh AS, Bhatti MS.
    J Ayub Med Coll Abbottabad; 2001 Aug; 13(2):5-10. PubMed ID: 11732224
    [Abstract] [Full Text] [Related]

  • 7. [Adverse effects related to the use of antitubercular drugs in psychiatric centers: retrospective study at the Philippe Pinel CH in Amiens 1994].
    Decocq G, Compagnon M, Andréjak M, Guedj B, Doutrellot C.
    Therapie; 1996 Aug; 51(5):543-9. PubMed ID: 9138390
    [Abstract] [Full Text] [Related]

  • 8. [Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results].
    Fujino T, Hasegawa N, Satou R, Komatsu H, Kawada K.
    Kekkaku; 1998 Jul; 73(7):471-6. PubMed ID: 9739579
    [Abstract] [Full Text] [Related]

  • 9. [Evaluation of the streptomycin twice weekly with INH and RFP for initial therapy of pulmonary tuberculosis].
    Toyota E, Suzuki T, Tagawa K, Takahara M, Ito M, Arai T, Kabe J, Baba H.
    Kekkaku; 1994 Sep; 69(9):559-63. PubMed ID: 7967317
    [Abstract] [Full Text] [Related]

  • 10. [Clinico-laboratory diagnosis of adverse reactions in children to antitubercular drugs in different combinations].
    Kazakov KS, Zakharova RI, Absadykova FT.
    Probl Tuberk; 1990 Sep; (9):40-2. PubMed ID: 2274509
    [Abstract] [Full Text] [Related]

  • 11. [Administration of antituberculous drugs to subjects with basic diseases. 2. Clinical studies of INH and RFP therapy on tuberculous patients with liver diseases].
    Yamazaki M.
    Kekkaku; 1987 Dec; 62(12):667-71. PubMed ID: 3448352
    [No Abstract] [Full Text] [Related]

  • 12. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
    Kang WL, Xie YG, Tan WG, Chu NH, Li L, You YH, Yang YZ, Wang XM, Yan XL, Miao ZP, Duanmu HJ.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
    [Abstract] [Full Text] [Related]

  • 13. [Anti-tuberculosis chemotherapy].
    Wada M.
    Kekkaku; 2007 Oct; 82(10):771-81. PubMed ID: 18018601
    [Abstract] [Full Text] [Related]

  • 14. [Frequency and pattern of adverse reactions due to treatment of patients with pulmonary tuberculosis with antitubercular reserve drugs].
    Chukanov VI, Kaminskaia GO, Livchane E.
    Probl Tuberk Bolezn Legk; 2004 Oct; (10):6-10. PubMed ID: 15568310
    [Abstract] [Full Text] [Related]

  • 15. Current HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone-free antituberculosis treatment in Yaounde, Cameroon.
    Kuaban C, Bercion R, Koula-Shiro S.
    Cent Afr J Med; 1998 Feb; 44(2):34-7. PubMed ID: 9675969
    [Abstract] [Full Text] [Related]

  • 16. [Clinical and laboratory studies in patients with pulmonary tuberculosis treated with pyrazinamide].
    Savula MM, Smolenko MI, Romaniuk MD, Slivka IuI.
    Probl Tuberk; 1990 Feb; (11):25-8. PubMed ID: 2290809
    [Abstract] [Full Text] [Related]

  • 17. [Desensitization therapy for antituberculous drugs].
    Kobashi Y, Okimoto N, Matsushima T, Abe T, Nishimura K, Shishido S, Kawahara S, Shigeto E, Takeyama H, Kuraoka T.
    Kekkaku; 2000 Sep; 75(9):521-6. PubMed ID: 11068368
    [Abstract] [Full Text] [Related]

  • 18. [A case of drug-resistant pulmonary tuberculosis treated successfully following disappearance of rifampicin resistance after 17 years' chemotherapy].
    Shigeto E, Murakami I, Yokosaki Y.
    Kekkaku; 2001 Apr; 76(4):379-83. PubMed ID: 11398329
    [Abstract] [Full Text] [Related]

  • 19. [Side effects of antituberculous drugs observed within six months after admission. Tuberculosis Research Committee, Ryoken (author's transl)].
    Kekkaku; 1975 Jun; 50(6):161-7. PubMed ID: 1185917
    [No Abstract] [Full Text] [Related]

  • 20. [Intensive chemotherapy tolerance in old patients with pulmonary tuberculosis].
    Karachunskiĭ MA, Kaminskaia GO, Uvarova TE.
    Probl Tuberk Bolezn Legk; 2004 Jun; (9):25-8. PubMed ID: 15532463
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.